This result was surprising because, while frequent MSH6 and MSH3 homopolymer alterations have previously been described in large-scale compendium studies of MMRd cancers9–11, these subclonal homopolymer mutations had so far been disregarded as neutral passengers in the context of preceding (truncal) MMR deficiency. The gene discussed is MSH3; the disease is mismatch repair cancer syndrome 1.